PW Medtech Group Limited (HKG:1358)

Market Cap	1.68B +6.5%
Revenue (ttm)	916.40M +7.1%
Net Income	105.02M -37.4%
EPS	0.07 -36.1%
Shares Out	1.45B
PE Ratio	16.69
Forward PE	n/a
Dividend	0.06 (5.52%)
Ex-Dividend Date	Jul 2, 2026

Volume	230,000
Open	1.170
Previous Close	1.160
Day's Range	1.160 - 1.170
52-Week Range	0.970 - 1.630
Beta	0.75
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 27, 2026

About PW Medtech Group

PW Medtech Group Limited, an investment holding company, operates as a medical device company in China, India, the Americas, Africa, the rest of Asia, and internationally. It operates in three segments: Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business. The company offers advanced infusion sets, such as non-PVC-based infusion sets, precision filter infusion sets, light-resistant infusion sets, intravenous cannula products, and insulin needles and pens; hemodialysis and blood purification medical ...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 1997
• Employees: 1,440
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 1358

Financial Performance

In 2025, PW Medtech Group's revenue was 823.51 million, an increase of 7.10% compared to the previous year's 768.90 million. Earnings were 94.37 million, a decrease of -37.41%.

Financial numbers in CNY